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Edited by Miguel De la RosaAbstract Green tea polyphenols, which have the ability to inhi-
bit angiogenesis, form complexes with Cu(II), a known potent
stimulator of blood vessel proliferation. Copper complexes of
()-epicatechin gallate and ()-epigallocatechin gallate were
found to inhibit the enzymatic activity of Ribonuclease A (RNase
A) as revealed by an agarose gel based assay and urea denatured
gel electrophoresis. The copper complexes were found to be non-
competitive inhibitors of RNase A with inhibition constants in
the micromolar range. Changes in the secondary structure of
the protein are found to occur due to the interaction as revealed
from Fourier transform infrared and circular dichroism studies.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cellular RNA levels are controlled post-transcriptionally by
ribonucleases of varying speciﬁcity [1]. Angiogenin [2], eosino-
phil-derived neurotoxin (EDN) [3] and bovine seminal Ribo-
nuclease [4] are among the myriad of proteins with
ribonuclease activity having signiﬁcant homology to RNase
A in addition to their biological activities [5]. Angiogenin, a
member of the ribonuclease superfamily showing 60%
homology with RNase A [6], is a potent inducer of angiogen-
esis, the process of new blood vessel growth. We have investi-
gated the eﬀect of green tea polyphenols isolated from green
tea leaves on angiogenin induced angiogenesis [7]. Subsequent
studies indicated that the major green tea polyphenol, ()-epi-
gallocatechin gallate inhibited the ribonucleolytic activity of
RNase A in a non-competitive manner [8].
The anticancer and antiangiogenic activities of the major
green tea polyphenols; ()-epicatechin (EC), ()-epicatechin
gallate (ECG), ()-epigallocatechin (EGC), and ()-epigallo-
catechin gallate (EGCG) [9] (Fig. 1) are well known [10,11].Abbreviations: RNase A, Ribonuclease A; ECG, ()-epicatechin gall-
ate; EGCG, ()-epigallocatechin gallate; HSA, human serum albumin;
2 0,30-cCMP, Cytidine 2 0,3 0 cyclic monophosphate; tRNA, transfer
ribonucleic acid; Mes, 4-morpholine ethanesulphonic acid; FT-IR,
Fourier transformed infrared; CD, circular dichroism
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doi:10.1016/j.febslet.2006.07.054Copper, on the other hand, an essential trace element present
in the diet, is an important cofactor for angiogenesis [12]. A
number of drugs have been used to reduce copper levels in
blood via chelation. Penicillamine [13], captopril [14] and
ammonium tetrathiomolybdate [15] are known chelators of
copper that have been used for antiangiogenic therapy, though
side eﬀects are also observed [16]. Thus copper complexation
by naturally occurring compounds from dietary constituents
that have the ability to inhibit angiogenesis on their own can
be eﬀectively exploited in the development of novel antiangio-
genic compounds.
We have investigated the eﬀect of the copper complexes of
ECG and EGCG on the enzymatic activity of RNase A, since
the presence of the gallate moiety has shown to have an inhib-
itory eﬀect on several proteins [17–20]. Agarose gel and urea
denatured gel electrophoreses experiments were conducted fol-
lowed by kinetic experiments. Secondary structural changes
occurring due to the interaction of the complexes with RNase
A were studied by Fourier transform infrared and circular
dichroism studies.2. Materials and methods
2.1. Materials
RNase A, yeast transfer ribonucleic acid (tRNA), cytidine 2 0,3 0 cyc-
lic monophosphate (2 0,3 0-cCMP), ECG and EGCG were from Sigma–
Aldrich, D2O from Acros Organics and other reagents from SRL In-
dia. A Perkin–Elmer UV–Vis spectrophotometer (Lambda 25) was
used for UV measurements. Concentrations were determined using
the following data: RNase A e278.5 = 9800 M
1 cm1 [21]; 2 0,3 0-cCMP
e268 = 8500 M
1 cm1 [22]; ECG and EGCG, e270 = 12443 and
11920 M1 cm1 [23], respectively.
2.2. Complexation of ECG and EGCG with Cu(II) by UV spectroscopy
The absorption spectra were obtained on successive addition of
0.58 mM CuSO4 to 0.057 mM ECG and 0.17 mM EGCG in 20 mM
acetate buﬀer, pH 5.0, to reach metal:polyphenol ratios ranging from
0.2:1 to 4.4:1 and 0.2:1 to 6.8:1, respectively. The stoichiometry of
the polyphenol–metal complex was determined by the mole-ratio
method using a Jobs plot. The absorbance of each solution was mea-
sured at 270 nm (kmax of the polyphenols) and plotted against the mole
fraction of the respective polyphenol. The breakpoint in the plot cor-
responds to the mole fraction of the polyphenol in its metal complex
giving the binding stoichiometry.
2.3. Agarose gel-based assay
Inhibition of RNase A by the copper complexes was checked qual-
itatively by the degradation of tRNA in an agarose gel. 20 ll of RNase
A (3.43 lM) was mixed with 20 ll each of 0.027 mM ECG, EGCG and
their copper complexes and the resulting solutions were incubated for
6 h. 20 ll aliquots of the incubated mixtures were then mixed withblished by Elsevier B.V. All rights reserved.
Fig. 1. Structure of the four major green tea polyphenols.
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free water) and incubated for another 30 min. 10 ll of sample buﬀer
which contains 10% glycerol and 0.025% bromophenol blue was added
to the mixture. 15 ll from each solution was extracted and loaded onto
a 1.1% agarose gel. The undegraded tRNA was visualized by ethidium
bromide staining under UV light.
2.4. Urea denatured gel electrophoresis
20 ll of 0.97 lM of RNase A was incubated with 20 ll of 0.1 mM
ECG, EGCG and their copper complexes for 3 h. 20 ll of each incu-
bated mixture was taken and mixed with 20 ll tRNA (5.0 mg/ml) solu-
tion and incubated for another 30 min. 15 ll of the gel loading buﬀer
(0.01% bromophenol blue and 10% glycerol in 1· TAE buﬀer, pH 8.0)
was added to each incubated solutions. 15 ll from each mixture was
loaded onto a 15% polyacrylamide gel consisting of 7 M urea. The
gel was visualized after ﬁxing with 7.5% acetic acid and silver staining.Fig. 2. Absorption spectra of (a) ECG and (b) EGCG with increasing concen
complexes monitored at 270 nm.2.5. Precipitation assay
The inhibition of the ribonucleolytic activity of RNase A was as-
sayed by the precipitation method as described by Bond [24]. 10 ll
of RNase A (5.6 lM) was mixed with 0–0.061 mM of the complexes
and incubated for 2 h. 20 ll of the solutions was then mixed with
40 ll of tRNA, 40 ll of phosphate buﬀer of pH 6.5 containing 5 mM
EDTA and 0.5 mg/ml HSA. After incubation at 25 C for 30 min,
200 ll of ice-cold 1.14 N perchloric acid containing 6 mM uranyl ace-
tate was added to quench the reaction. The solution was kept in ice for
another 30 min and centrifuged at 4 C at 12000 rpm for 5 min. 100 ll
of the supernatant was diluted to 1 ml and the change in absorbance
measured at 260 nm and compared to a control set.
2.6. Inhibition kinetics
The inhibition of RNase A by the copper complexes of ECG and
EGCG was assessed by a spectrophotometric method as described
by Anderson et al. [22]. The assay was performed in oligo vinylsul-
phonic acid free 0.1 M Mes–NaOH buﬀer, pH 6.0, containing 0.1 M
NaCl using 2 0,3 0-cCMP as the substrate [25]. The inhibition kinetics
for EGCG has been previously reported from this laboratory [8].
The substrate concentrations ranged from 0.04 to 0.09 mM and the
inhibitor concentrations from 0 to 0.007 mM, with RNase A at
10 lM. The nature of inhibition and the inhibition constants was ob-
tained from Lineweaver–Burk plots.
2.7. Fourier transformed infrared (FT-IR) studies
16.2 mg/ml (0.67 mM) RNase A was dissolved in 20 mM phosphate
buﬀer of pD 7.2 in 99.9% D2O. RNase A:ligand ratios of 1:0.5 and
1:1.5 were prepared for the two complexes. FT-IR measurements were
carried out at 25 C on a Nexus-870 FT-IR spectrometer (Thermo Nic-
olet Corporation) equipped with a germanium-attenuated total reﬂec-
tion (ATR) accessory, a DTGS KBr detector and a KBr beam splitter.
Secondary structure information of uncomplexed and complexed
RNase A were determined following the method of Bayler and Susi
[26] as described elsewhere [27].tration of CuSO4. Jobs plots of (c) Cu(II)-ECG and (d) Cu(II)-EGCG
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CD measurements were made on a Jasco-810 automatic recording
spectrophotometer, using 2 mm path length at 25 C. The RNase A
concentration was 6.44 lM and complex mixtures with RNase
A:ligand ratios of 1:0.5 and 1:1.5 were analyzed. Results were ex-
pressed as ellipticity (H) and secondary structure determined using
DICHROWEB [28].Fig. 3. (a) Agarose gel based assay for the inhibition of RNase A by
ECG, EGCG and their copper complexes, (b) urea denaturing gel for
RNase A inhibition with ECG, EGCG and their copper complexes.
Fig. 4. Relative ribonucleolytic activity plots of inhibition of RNase A
by ECG (-j-), EGCG (-r-), Cu(II)-ECG (-m-) and Cu(II)-EGCG
(--).3. Results and discussion
Reports on the ability of green tea polyphenols to inhibit
angiogenesis in vivo [11] combined with promising results for
copper reduction therapy [15] prompted us to probe the eﬀect
of copper complexes of two major green tea polyphenols on
the enzymatic activity of RNase A. It is possible to extend
these studies to proteins of the ribonuclease superfamily that
exhibit unusual biological properties.
Spectrophotometric analysis on the complex formation of
ECG and EGCG with Cu(II) indicated that with an increase
in the concentration of Cu(II), the absorbance at 270 nm de-
creased with the formation of a broad shoulder at 320–
330 nm. Chelation studies of copper with ﬂavonoid com-
pounds such as quercetin, myricetin, catechin and luteolin
report a similar spectroscopic shift [29]. The presence of two
isobestic points at 263 and 290 nm in the spectra for Cu(II)-
ECG and at 257 and 295 nm for Cu(II)-EGCG points toward
the occurrence of two consecutive equilibria during complex
formation (Fig. 2(a) and (b)). Jobs plots to determine the stoi-
chiometry of the complexes are given in Fig. 2(c) and (d). The
breakpoint at 0.3342 for ECG and 0.3247 for EGCG indicates
that the stoichiometry of polyphenol to metal is 1:2 for both
cases.
Electrophoresis experiments to check the eﬀect on the ribo-
nucleolytic activity of RNase A indicate that the complexes in-
hibit the enzymatic activity. The agarose gel based assay,
monitored degradation of tRNA by RNase A and the eﬀect
of the complexes (Fig. 3(a)). The most intense band observed
in lane 1 is of control tRNA. The faint band in lane 2 indicates
the degradation of tRNA by RNase A. The diﬀerential inten-
sity of bands in lanes 3, 4, 5, 6 qualitatively indicates the degree
of RNase A inhibition by the Cu(II)-EGCG complex, Cu(II)-
ECG complex, EGCG and ECG, respectively. Similar results
obtained from the urea denaturing polyacrylamide gel electro-
phoresis are shown in Fig. 3(b). Control tRNA in lane 1
showed the least degradation; uncomplexed RNase A de-
graded tRNA to the highest extent in lane 2; reduced degrada-
tion patterns of tRNA are observed in lanes 3, 4, 5 and 6.
These results show that Cu(II)-ECG and Cu(II)-EGCG act
as eﬀective inhibitors of RNase A.
A quantitative estimation of the relative inhibitory power of
the polyphenols and their complexes is obtained from the pre-
cipitation assay. The plots of relative ribonucleolytic activity
versus inhibitor concentration in Fig. 4 indicate that the
Cu(II)-EGCG complex is more eﬀective compared to the
Cu(II)-ECG complex. It may be noted that the inhibitory eﬃ-
cacy of the copper complexes of the polyphenols is greater
than the uncomplexed polyphenols. Kinetic experiments indi-
cate that the two complexes behave as non-competitive inhib-
itors (Fig. 5). The inhibition constant values obtained for
Cu(II)-ECG and Cu(II)-EGCG are 42 ± 1 and 23 ± 4 lM,
respectively. Our previous study has shown that the inhibitionconstants for the inhibition of RNase A by EGCG and ECG
were 81 lM [8] and 392 ± 23 lM [30], respectively. The inhibi-
tion constant values obtained for Cu(II)-ECG and Cu(II)-
EGCG correlate well with the results from the precipitation as-
say with a correlation coeﬃcient of 0.93.
Protein amide I bands at 1645–1650 cm1 (mainly C‚O
stretching) and the amide II band at 1548–1560 cm1 (C–N
stretching coupled with N–H bending mode) [26] change
upon ligand binding. Hydrogen bonding and the coupling
Fig. 5. Lineweaver–Burk plots for inhibition of RNase A by (a) Cu(II)-ECG and (b) Cu(II)-EGCG. Concentrations: 0.0067 mM (j), 0.004 mM (m),
0 mM (r).
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conformational sensitivity of the amide bands of the protein.
Spectral ranges from 1610 to 1632 cm1, 1636 to 1644 cm1,Fig. 6. FT-IR diﬀerence spectra of RNase A complexes with (a)
Cu(II)-ECG and (b) Cu(II)-EGCG at two diﬀerent concentrations,
RNase A:polyphenol 1:0.5 (ddd) and 1:1.5 (–d–) (left-hand axis)
with FT-IR spectra of free RNase A (–) (right-hand axis).1650 to 1662 cm1 and 1665 to 1680 cm1 in the amide I re-
gion are attributed to b-sheet, random coil, a-helix and turn
structures, respectively [31,32]. The peak positions of the
amide I and II bands in the two diﬀerence spectra of each
complex shift with a simultaneous change in the relative
intensity (Fig. 6), indicating a change in the secondary struc-
ture of the protein. In the diﬀerence spectra of Cu(II)-ECG at
a protein ligand ratio of 1:1.5, the peak maximum at
1643 cm1 with a shoulder at 1660 cm1 means that there
are changes in the a-helical structure. In case of Cu(II)-
EGCG at a protein ligand ratio of 1:1.5, changes in the peak
and shoulder positions reﬂect the changes in a-helix content
(1662 cm1) and random structure (1644 cm1). The increase
in intensity observed in the diﬀerence spectra between 1546
and 1552 cm1 for the two complexes can be attributed to
the interaction of the polyphenols with the backbone of the
protein. A quantitative analysis of the secondary structural
elements is given in Table 1.
CD spectroscopic studies of free RNase A and with Cu(II)-
ECG and Cu(II)-EGCG also indicate a perturbation of the
secondary structure (Fig. 7). The eﬀect on the secondary
structure is more pronounced for Cu(II)-EGCG. Secondary
structure content was determined using DICHROWEB for
RNase A polyphenol complexes of 1:0.5 and 1:1.5 ratios
and compared with FT-IR results (Table 1). We observe that
for both FT-IR and CD studies there is an increase in the a-
helix content (8–9%) with a concomitant reduction in random
structure. The increase in a-helix content of RNase A has
also been observed with 3 0 azido-3 0 deoxythymidine (AZT)
[33].
This study suggests that the copper complexes are more po-
tent inhibitors of RNase A than the parent polyphenols. Based
on the structural homology between RNase A and angiogenin
these complexes can subsequently be used for antiangiogenic
therapy through copper chelation. Further studies are under-
way to ascertain the eﬀect of the complexes on the angiogenic
activity of angiogenin since the enzymatic and biological activ-
ities of this protein are related. These studies also provide a
guideline as to how antangiogenic compounds based on these
complexes may be developed to limit undesirable vascular pro-
liferation.
Fig. 7. CD spectra of (a) RNase A-Cu(II)-ECG and (b) RNase A-Cu(II)-EGCG complexes. Free RNase A (–), RNase A:complex 1:0.5 (-  -) and
RNase A:complex 1:1.5 (-m-).
Table 1
Secondary structures of free RNase A and RNase A complexes with Cu(II)-ECG and Cu(II)-EGCG from FT-IR and CD studies
a-Helix (%) b-Sheet (%) Random coil (%) Turn (%)
FT-IR CD FT-IR CD FT-IR CD FT-IR CD
RNase A 22.0 15.0 38.0 42.0 22.0 26.0 19.0 18.0
RNase A:Cu(II)-ECG
1:0.5 19.0 14.0 45.0 43.0 24.0 25.0 11.0 17.0
1:1.5 18.0 14.0 38.0 44.0 28.0 25.0 16.0 17.0
RNase A:Cu(II)-EGCG
1:0.5 20.0 15.0 38.0 44.0 16.0 19.0 25.0 23.0
1:1.5 31.0 23.0 38.0 44.0 14.0 15.0 16.0 18.0
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